<p>TD Waterhouse Canada Inc. 在最近向證券交易委員會提交的 13F 表格中表示，在第四季度將其在 TransMedics Group, Inc. (NASDAQ:TMDX - 免費報告) 的持股減少了 90.8%。該機構投資者在季度內出售了 4,173 股後，持有該公司 425 股股票。TD Waterhouse Canada Inc. 在 TransMedics Group 的持股在最近的報告期末價值為 26,000 美元。</p>
<p>獲取 <strong>TransMedics Group</strong> 警報：</p>
<ul>
<li>3 只遠低於 52 周高點且具有強勁增長預期的股票</li>
</ul>
<p>其他對沖基金和機構投資者最近也對該公司的持股進行了調整。Vanguard Group Inc. 在第四季度將其在 TransMedics Group 的持股增加了 1.1%。Vanguard Group Inc. 目前擁有 3,635,919 股該公司的股票，價值 226,700,000 美元，此前在該期間內又增持了 40,860 股。FIL Ltd 在第四季度將其在 TransMedics Group 的持股增加了 28.0%。FIL Ltd 目前擁有 1,000,358 股該公司的股票，價值 62,372,000 美元，此前在該期間內又增持了 218,961 股。Geode Capital Management LLC 在第四季度將其在 TransMedics Group 的持股增加了 1.2%。Geode Capital Management LLC 目前擁有 772,744 股該公司的股票，價值 48,191,000 美元，此前在該期間內又增持了 8,954 股。Wasatch Advisors LP 在第四季度將其在 TransMedics Group 的持股增加了 83.3%。Wasatch Advisors LP 目前擁有 441,354 股該公司的股票，價值 27,518,000 美元，此前在該期間內又增持了 200,603 股。最後，Emerald Advisers LLC 在第四季度將其在 TransMedics Group 的持股增加了 146.3%。Emerald Advisers LLC 目前擁有 371,711 股該公司的股票，價值 23,176,000 美元，此前在該期間內又增持了 220,804 股。99.67% 的股票由機構投資者持有。</p>
<h2>分析師評級上調與下調</h2>
<p>TMDX 已成為多份研究分析師報告的主題。Needham &amp; Company LLC 在 4 月 23 日的報告中重申了對 TransMedics Group 股票的 &#34;持有&#34; 評級。Canaccord Genuity Group 在 3 月 11 日的研究報告中重申了 &#34;買入&#34; 評級，並對 TransMedics Group 股票設定了 104.00 美元的目標價。三位分析師對該股票給予了持有評級，七位給予了買入評級，一位給予了強烈買入評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 &#34;適度買入&#34;，共識目標價為 122.70 美元。</p>
<p><strong>獲取我們對 TransMedics Group 的最新分析</strong></p>
<h2>TransMedics Group 股票表現</h2>
<p>NASDAQ TMDX 的股票在週二開盤價為 90.19 美元。該股票的 50 日移動平均價格為 74.67 美元，200 日移動平均價格為 77.10 美元。TransMedics Group, Inc. 的 52 周低點為 55.00 美元，52 周高點為 177.37 美元。該公司的債務與股本比率為 2.42，速動比率為 7.33，流動比率為 8.20。該股票的市值為 30.5 億美元，市盈率為 95.95，貝塔係數為 2.14。</p>
<h2>關於 TransMedics Group</h2>
<p>(免費報告)</p>
<p>TransMedics Group, Inc. 是一家商業階段的醫療技術公司，致力於為美國及國際上的終末期器官衰竭患者轉變器官移植治療。該公司提供器官護理系統 (OCS)，這是一種便攜式器官灌注、優化和監測系統，利用其專有和定製的技術在人體外複製接收器官的近生理條件。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們更看好的股票，勝過 TransMedics Group</li>
<li>WallStreetBets 是什麼，它們正在瞄準哪些股票？</li>
<li>2025 年最佳防禦股票……到目前為止</li>
<li>如何做空納斯達克：易於遵循的指南</li>
<li>Alphabet 在強勁的財報和回購公告後反彈</li>
<li>深入瞭解買賣價差</li>
<li>出售台積電會是巴菲特最大的遺憾嗎？</li>
</ul>
<p><strong>想看看其他對沖基金持有的 TMDX 嗎？</strong> 訪問 HoldingsChannel.com 獲取 TransMedics Group, Inc. (NASDAQ:TMDX - 免費報告) 的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VE1EWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VE1EWA"/></p>
<p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前經過 MarketBeat 編輯團隊的審查。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 TransMedics Group 嗎？</h2>
<p>在你考慮 TransMedics Group 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 TransMedics Group 並不在名單上。</p>
<p>雖然 TransMedics Group 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

TMDX

<p>TD Waterhouse Canada Inc. 在第四季度通過出售 4,173 股大幅減少了對 TransMedics Group, Inc. (NASDAQ:TMDX) 的持股，持股量減少了 90.8%。該公司目前持有 425 股，價值 26,000 美元。其他機構投資者，包括先鋒集團和 FIL 有限公司，也調整了他們在 TMDX 的持倉。該股票目前的市值為 30.5 億美元，平均評級為 “適度買入”，共識目標價為 122.70 美元</p>

<p>TD Waterhouse Canada Inc. trimmed its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 90.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The institutional investor owned 425 shares of the company's stock after selling 4,173 shares during the quarter. TD Waterhouse Canada Inc.'s holdings in TransMedics Group were worth $26,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>TD Waterhouse Canada Inc. 在最近向證券交易委員會提交的 13F 表格中表示，在第四季度將其在 TransMedics Group, Inc. (NASDAQ:TMDX - 免費報告) 的持股減少了 90.8%。該機構投資者在季度內出售了 4,173 股後，持有該公司 425 股股票。TD Waterhouse Canada Inc. 在 TransMedics Group 的持股在最近的報告期末價值為 26,000 美元。</p>
</div><p>Get <strong>TransMedics Group</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>TransMedics Group</strong> 警報：</p>
</div><ul>
<li>3 Stocks Well Below 52-Week Highs With Strong Growth Projections</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只遠低於 52 周高點且具有強勁增長預期的股票</li>
</ul>
</div><p>Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of TransMedics Group by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 3,635,919 shares of the company's stock worth $226,700,000 after acquiring an additional 40,860 shares during the period. FIL Ltd raised its holdings in shares of TransMedics Group by 28.0% during the fourth quarter. FIL Ltd now owns 1,000,358 shares of the company's stock worth $62,372,000 after acquiring an additional 218,961 shares during the period. Geode Capital Management LLC raised its holdings in shares of TransMedics Group by 1.2% during the fourth quarter. Geode Capital Management LLC now owns 772,744 shares of the company's stock worth $48,191,000 after acquiring an additional 8,954 shares during the period. Wasatch Advisors LP raised its holdings in shares of TransMedics Group by 83.3% during the fourth quarter. Wasatch Advisors LP now owns 441,354 shares of the company's stock worth $27,518,000 after acquiring an additional 200,603 shares during the period. Finally, Emerald Advisers LLC raised its holdings in shares of TransMedics Group by 146.3% during the fourth quarter. Emerald Advisers LLC now owns 371,711 shares of the company's stock worth $23,176,000 after acquiring an additional 220,804 shares during the period. 99.67% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他對沖基金和機構投資者最近也對該公司的持股進行了調整。Vanguard Group Inc. 在第四季度將其在 TransMedics Group 的持股增加了 1.1%。Vanguard Group Inc. 目前擁有 3,635,919 股該公司的股票，價值 226,700,000 美元，此前在該期間內又增持了 40,860 股。FIL Ltd 在第四季度將其在 TransMedics Group 的持股增加了 28.0%。FIL Ltd 目前擁有 1,000,358 股該公司的股票，價值 62,372,000 美元，此前在該期間內又增持了 218,961 股。Geode Capital Management LLC 在第四季度將其在 TransMedics Group 的持股增加了 1.2%。Geode Capital Management LLC 目前擁有 772,744 股該公司的股票，價值 48,191,000 美元，此前在該期間內又增持了 8,954 股。Wasatch Advisors LP 在第四季度將其在 TransMedics Group 的持股增加了 83.3%。Wasatch Advisors LP 目前擁有 441,354 股該公司的股票，價值 27,518,000 美元，此前在該期間內又增持了 200,603 股。最後，Emerald Advisers LLC 在第四季度將其在 TransMedics Group 的持股增加了 146.3%。Emerald Advisers LLC 目前擁有 371,711 股該公司的股票，價值 23,176,000 美元，此前在該期間內又增持了 220,804 股。99.67% 的股票由機構投資者持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級上調與下調</h2>
</div><p>TMDX has been the topic of a number of research analyst reports. Needham &amp; Company LLC restated a &#34;hold&#34; rating on shares of TransMedics Group in a report on Wednesday, April 23rd. Canaccord Genuity Group reiterated a &#34;buy&#34; rating and issued a $104.00 price target on shares of TransMedics Group in a research note on Tuesday, March 11th. Three analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $122.70.</p>
<div class="lb-trans"><p>TMDX 已成為多份研究分析師報告的主題。Needham &amp; Company LLC 在 4 月 23 日的報告中重申了對 TransMedics Group 股票的 &#34;持有&#34; 評級。Canaccord Genuity Group 在 3 月 11 日的研究報告中重申了 &#34;買入&#34; 評級，並對 TransMedics Group 股票設定了 104.00 美元的目標價。三位分析師對該股票給予了持有評級，七位給予了買入評級，一位給予了強烈買入評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 &#34;適度買入&#34;，共識目標價為 122.70 美元。</p>
</div><p><strong>Get Our Latest Analysis on TransMedics Group</strong></p>
<div class="lb-trans"><p><strong>獲取我們對 TransMedics Group 的最新分析</strong></p>
</div><h2>TransMedics Group Stock Performance</h2>
<div class="lb-trans"><h2>TransMedics Group 股票表現</h2>
</div><p>Shares of NASDAQ TMDX opened at $90.19 on Tuesday. The stock has a 50 day moving average price of $74.67 and a 200 day moving average price of $77.10. TransMedics Group, Inc. has a 52 week low of $55.00 and a 52 week high of $177.37. The company has a debt-to-equity ratio of 2.42, a quick ratio of 7.33 and a current ratio of 8.20. The stock has a market capitalization of $3.05 billion, a PE ratio of 95.95 and a beta of 2.14.</p>
<div class="lb-trans"><p>NASDAQ TMDX 的股票在週二開盤價為 90.19 美元。該股票的 50 日移動平均價格為 74.67 美元，200 日移動平均價格為 77.10 美元。TransMedics Group, Inc. 的 52 周低點為 55.00 美元，52 周高點為 177.37 美元。該公司的債務與股本比率為 2.42，速動比率為 7.33，流動比率為 8.20。該股票的市值為 30.5 億美元，市盈率為 95.95，貝塔係數為 2.14。</p>
</div><h2>About TransMedics Group</h2>
<div class="lb-trans"><h2>關於 TransMedics Group</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>TransMedics Group, Inc, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.</p>
<div class="lb-trans"><p>TransMedics Group, Inc. 是一家商業階段的醫療技術公司，致力於為美國及國際上的終末期器官衰竭患者轉變器官移植治療。該公司提供器官護理系統 (OCS)，這是一種便攜式器官灌注、優化和監測系統，利用其專有和定製的技術在人體外複製接收器官的近生理條件。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than TransMedics Group</li>
<li>What Is WallStreetBets and What Stocks Are They Targeting?</li>
<li>Best Defense Stocks in 2025... So Far</li>
<li>How to Short Nasdaq: An Easy-to-Follow Guide</li>
<li>Alphabet Rebounds After Strong Earnings and Buyback Announcement</li>
<li>A Deeper Look at Bid-Ask Spreads</li>
<li>Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 TransMedics Group</li>
<li>WallStreetBets 是什麼，它們正在瞄準哪些股票？</li>
<li>2025 年最佳防禦股票……到目前為止</li>
<li>如何做空納斯達克：易於遵循的指南</li>
<li>Alphabet 在強勁的財報和回購公告後反彈</li>
<li>深入瞭解買賣價差</li>
<li>出售台積電會是巴菲特最大的遺憾嗎？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding TMDX?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TransMedics Group, Inc. (NASDAQ:TMDX - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對沖基金持有的 TMDX 嗎？</strong> 訪問 HoldingsChannel.com 獲取 TransMedics Group, Inc. (NASDAQ:TMDX - 免費報告) 的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VE1EWA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=TMDX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前經過 MarketBeat 編輯團隊的審查。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in TransMedics Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 TransMedics Group 嗎？</h2>
</div><p>Before you consider TransMedics Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 TransMedics Group 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TransMedics Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 TransMedics Group 並不在名單上。</p>
</div><p>While TransMedics Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 TransMedics Group 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

TD Waterhouse Canada Inc. 出售了 4,173 股 TransMedics Group, Inc.（NASDAQ 代碼：TMDX）的股票